Table 3.
Characteristic | No. | Median survival (mo) | p-valuea) (univariate) | p-valueb) (multivariate) |
---|---|---|---|---|
Sex | ||||
Male | 8 | 28.4 | 0.601 | 0.204 |
Female | 25 | 23.1 | ||
Age at primary radiotherapy, median (yr) | ||||
≤ 44 | 17 | 34.9 | 0.886 | - |
> 44 | 16 | 23.1 | ||
Age at diagnosis of RIS, median (yr) | ||||
≤ 55 | 18 | 115.2 | 0.218 | 0.010c) |
> 55 | 15 | 23.1 | ||
Latency, median | ||||
≤ 12 | 16 | 115.2 | 0.233 | 0.176 |
> 12 | 17 | 23.3 | ||
Chemotherapy for primary cancer | ||||
Yes | 21 | 34.9 | 0.704 | - |
No | 12 | 28.4 | ||
RIS location | ||||
Trunk | 25 | 34.9 | 0.613 | 0.865 |
Head and neck | 8 | 14.8 | ||
RIS histology | ||||
MFH | 11 | 124.0 | 0.121 | 0.376 |
Osteosarcoma | 12 | 23.3 | ||
Others | 10 | 14.8 | ||
Tumor size (cm) | ||||
≤ 5 | 19 | 34.9 | 0.858 | 0.284 |
> 5 | 14 | 23.3 | ||
Tumor depth | ||||
Deep | 27 | 22.2 | 0.980 | 0.320 |
Superficial | 6 | 34.9 | ||
Treatment | ||||
Curative | 19 | 115.2 | 0.001 | 0.001c) |
Palliation | 14 | 8.0 |
RIS, radiation induced sarcoma; MFH, malignant histiocytoma.
Log-rank test,
Cox regression analysis,
Statistically significant.